BUCHANG PHARMA: Shandong Danhong plans to sign a technology transfer contract with Shandong University of Traditional Chinese Medicine Affiliated Hospital for 15 million yuan
BUCHANG PHARMA announced that its holding subsidiary Shandong Danhong intends to sign a technology transfer contract with the Affiliated Hospital of Shandong University of Traditional Chinese Medicine, with a total transfer price of 15 million RMB. The contract involves the ownership of the technology for the Traditional Chinese Medicine Erzhi Regulating Menstruation Optimization Formula, aiming to enrich the product development pipeline and ultimately achieve industrial-scale production of the new drug. This transaction does not constitute a related party transaction and does not constitute a major asset reorganization
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments